Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.06 - $1.67 $38,792 - $61,116
36,597 New
36,597 $42,000
Q4 2023

Feb 14, 2024

SELL
$1.26 - $1.79 $216 - $307
-172 Reduced 0.47%
36,089 $60,000
Q3 2023

May 09, 2024

BUY
$1.61 - $2.54 $18,609 - $29,359
11,559 Added 46.79%
36,261 $65,000
Q3 2023

Apr 29, 2024

BUY
$1.61 - $2.54 $69 - $109
43 Added 0.12%
36,261 $65,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $69 - $109
43 Added 0.12%
36,261 $65,000
Q2 2023

Apr 29, 2024

BUY
$1.14 - $1.95 $41,288 - $70,625
36,218 New
36,218 $67,000
Q2 2023

Aug 10, 2023

BUY
$1.14 - $1.95 $13,128 - $22,456
11,516 Added 46.62%
36,218 $67,000
Q1 2023

May 09, 2024

BUY
$1.2 - $2.19 $29,642 - $54,097
24,702 New
24,702 $32.9 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $66 - $120
55 Added 0.22%
24,702 $32,000
Q4 2022

May 10, 2024

BUY
$1.63 - $3.52 $1,457 - $3,146
894 Added 3.76%
24,647 $41,000
Q4 2022

Jun 14, 2023

SELL
$1.63 - $3.52 $89 - $193
-55 Reduced 0.22%
24,647 $41,000
Q4 2022

Mar 22, 2023

BUY
$1.63 - $3.52 $1,457 - $3,146
894 Added 3.76%
24,647 $41,000
Q4 2022

Feb 15, 2023

BUY
$1.63 - $3.52 $1,457 - $3,146
894 Added 3.76%
24,647 $41,000
Q3 2022

May 10, 2024

SELL
$0.73 - $3.74 $232 - $1,193
-319 Reduced 1.33%
23,753 $74,000
Q3 2022

Jun 14, 2023

SELL
$0.73 - $3.74 $692 - $3,549
-949 Reduced 3.84%
23,753 $74,000
Q3 2022

Mar 22, 2023

SELL
$0.73 - $3.74 $232 - $1,193
-319 Reduced 1.33%
23,753 $74,000
Q3 2022

Nov 14, 2022

SELL
$0.73 - $3.74 $232 - $1,193
-319 Reduced 1.33%
23,753 $74,000
Q2 2022

May 10, 2024

BUY
$2.2 - $4.2 $52,958 - $101,102
24,072 New
24,072 $57,000
Q2 2022

Jun 20, 2023

SELL
$2.2 - $4.2 $1,386 - $2,646
-630 Reduced 2.55%
24,072 $57,000
Q2 2022

Mar 22, 2023

SELL
$2.2 - $4.2 $1,265 - $2,415
-575 Reduced 2.33%
24,072 $57,000
Q2 2022

Aug 11, 2022

BUY
$2.2 - $4.2 $52,958 - $101,102
24,072 New
24,072 $57,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.